Skip to main content
Biotest Aktiengesellschaft (ETR:BIO3)
Germany flag Germany · Delayed Price · Currency is EUR
30.00
-0.20 (-0.67%)
May 30, 2025, 5:36 PM CET

ETR:BIO3 Revenue

Biotest Aktiengesellschaft had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M with 6.08% growth.

Revenue (ttm)
635.20M
Revenue Growth
-18.83%
P/S Ratio
2.27
Revenue / Employee
254.59K
Employees
2,495
Market Cap
1.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024726.20M41.60M6.08%
Dec 31, 2023684.60M168.50M32.65%
Dec 31, 2022516.10M500.00K0.10%
Dec 31, 2021515.60M31.40M6.48%
Dec 31, 2020484.20M65.10M15.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.32B
Bayer Aktiengesellschaft 46.58B
Fresenius SE & Co. KGaA 22.13B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.17B
Fielmann Group AG 2.33B
Revenue Rankings

Biotest Aktiengesellschaft News

More News